Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;25:726-730

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shirai, H.
Right arrow Articles by Inagami, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shirai, H.
Right arrow Articles by Inagami, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

(Hypertension. 1995;25:726-730.)
© 1995 American Heart Association, Inc.


Articles

Mapping of G Protein Coupling Sites of the Angiotensin II Type 1 Receptor

Heigoro Shirai; Katsunobu Takahashi; Toshiaki Katada; Tadashi Inagami

From the Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tenn (H.S., T.I.); Department of Life Science, Tokyo Institute of Technology, Yokohama, Japan (K.T.); and Department of Physiological Chemistry, Faculty of Pharmaceutical Sciences, University of Tokyo (Japan) (T.K.).

Correspondence to Tadashi Inagami, PhD, Department of Biochemistry, Vanderbilt University School of Medicine, 23rd Ave S at Pierce Ave, LH663, Nashville, TN 37232.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract Angiotensin II type 1 (AT1) receptors have been identified in a wide variety of tissues, including the kidney, liver, adrenal gland, cardiovascular system, and brain. AT1 receptors also mediate complex signaling mechanisms that elicit a diversity of specific physiological effects. The rat AT1A receptor has seven transmembrane domains and couples with three distinct G proteins: Gq, Gi, and Go. But it is unknown which domains of AT1A couple with and activate each type of G protein. To identify the domains responsible for the activation of various types of G protein, we studied the effect of five different synthetic peptides representing different domains of cytosolic segments of the rat AT1A receptor on the binding of the 35S-labeled stable analogue of GTP, GTP{gamma}S. Peptides P-3, which is located in the N-terminal region of the putative third intracellular loop of AT1A (residues 216 through 230), and P-5 (residues 306 through 320), corresponding to the N-terminal region of the C-terminal tail, were found to activate purified Gi1, Gi2, and Go proteins. These results indicate that not only the third cytosolic loop but also the C-terminal cytosolic domain of AT1A is important for Gi1, Gi2, and Go protein coupling and activation.


Key Words: angiotensin II • receptors, angiotensin • G protein • signal transduction • rats


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Angiotensin II (Ang II) activates Gq, Gi, and Go proteins through the Ang II type 1 (AT1) receptor.1 2 3 The agonist-bound receptor promotes the exchange of GTP for GDP on the {alpha}-subunit of a G protein. The GTP-Gq{alpha} complex subsequently stimulates phospholipase C-ß4 5 ; Gi protein inhibits adenylate cyclase6 ; Go protein inhibits neuronal {omega}-conotoxin GVIA (CTX)–sensitive calcium channels7 8 ; and pertussis toxin–sensitive G proteins open L-type Ca2+ channels.9 The intrinsic GTPase activity of the {alpha}-subunit terminates the activation cycle by hydrolyzing GTP to inactive GDP. In studies of ß-adrenergic receptors, the role and mode of G protein action were demonstrated with a functionally active, reconstituted system composed of purified components of the signal transduction chain from several different sources.10 11

Ang II receptors from bovine adrenal,12 rat aortic vascular smooth muscle cells (VSMCs),13 and human sources14 15 have been cloned and sequenced. They have a degree of sequence homology with other G protein–linked receptors and share a basic structural motif. Based on the electron diffraction data of Henderson and Unwin16 on bacteriorhodopsin and the hydropathy profile for rhodopsin,17 a structural model of this receptor family was constructed that consists of seven hydrophobic transmembrane-spanning helical regions connected by extracellular and intracellular hydrophilic loops. The rat AT1A receptor consists of 359 amino acid residues. Functional domains involved in receptor–G protein interactions have been explored by site-directed mutagenesis.18 To further explore the receptor–G protein coupling domains, we prepared synthetic peptides corresponding to the regions of the intracellular loops of the AT1A receptor that are highly conserved among AT1 receptors from various species and tested their ability to compete with intact AT1A for interaction with purified heterotrimeric Gi1, Gi2, and Go. Unlike methods based on mutagenesis in which artifacts in structure and function cannot be excluded, the use of synthetic peptides allows one to perform experiments with unmodified components. Our results presented here made it possible to identify regions involved in the coupling of the AT1 receptor with Gi and Go proteins.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Reagents
[35S]GTP{gamma}S was purchased from DuPont-NEN. Filter membranes were purchased from Schleicher & Schuell. Other materials and reagents were purchased from Sigma Chemical Co or Fisher Scientific Co.

Cell Culture and Membrane Preparation
COS-7 cells were obtained from American Type Culture Collection. VSMCs were isolated from the thoracic aorta of Wistar-Kyoto rats as described previously.19 COS-7 cells and VSMCs (passages 7 through 15) were maintained in Dulbecco's modified Eagle's medium containing 10% fetal calf serum, 100 µg/mL streptomycin, and 100 U/mL penicillin in a humidified atmosphere at 37°C under 5% CO2. Cells were washed three times with Hanks' balanced salt solution, scraped, and collected by centrifugation at 1500g for 5 minutes. The plasma membrane fraction was prepared by a published method.18 Plasma membranes were suspended in 25 mmol/L HEPES-NaOH buffer (pH 7.4) containing 120 µmol/L MgCl2, 100 µmol/L EDTA, 5 µg/mL leupeptin, 5 µg/mL pepstatin A, and 40 µmol/L phenylmethylsulfonyl fluoride.

Synthetic Peptides and G Proteins
The peptides used in this study were synthesized by the solid-phase method and highly purified (95% to 99%) by high-performance liquid chromatography using a Nucleosil 5 C18 column eluted with a linear concentration gradient (0% to 60%) of CH3CN containing 0.1% trifluoroacetic acid. The lyophilized synthetic peptide was dissolved in water. Heterotrimeric forms of Gi1, Gi2, and Go proteins from bovine brain were purified to homogeneity.20

GTP{gamma}S Binding Assay
[35S]GTP{gamma}S binding promoted by synthetic peptides to 5 µg of membranes from COS-7 cells or VSMCs (100 mg/mL membrane) was measured in 25 mmol/L HEPES-NaOH buffer (pH 7.4) containing 120 µmol/L MgCl2, 100 µmol/L EDTA, and 100 nmol/L [35S]GTP{gamma}S in the absence of phospholipids as described by Okamoto et al.21 [35S]GTP{gamma}S binding to 10 nmol/L purified heterotrimeric G proteins was measured by the same method. Briefly, membranes or G proteins were incubated with or without synthetic peptides in the buffer indicated above at 37°C for the indicated period. Incubations were terminated by addition of 10 vol ice-cold stopping buffer containing 100 mmol/L Tris-HCl (pH 8.0), 25 mmol/L MgCl2, 100 mmol/L NaCl, and 20 µmol/L GTP. After materials were rapidly filtered through a nitrocellulose filter (pore size, 0.45 µm) and washed three times with the stopping buffer, the filter was counted in a liquid scintillation counter. GTP{gamma}S binding to the synthetic peptides was negligible at 10 µmol/L peptide. The maximal binding of [35S]GTP{gamma}S to G proteins was measured in the presence of 1 µmol/L GTP{gamma}S and 25 mmol/L Mg2+ at room temperature by the method of Northup et al22 as a positive control.

Statistics
Statistical analysis was carried out by one-way ANOVA followed by Duncan's new multiple range comparison.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
As shown in Fig 1, five peptides were synthesized corresponding to the conserved regions among AT1 receptors from various species of the second and third cytoplasmic loops and the N-terminal segment of the cytosolic C-terminal tail of the rat AT1A receptor. Each sequence consisted mainly of hydrophilic amino acids. The ability of each of the peptides to activate G proteins was tested with intact plasma membranes of COS-7 cells or VSMCs. Receptor-mediated G protein activation as reflected by the binding of the stable GTP analogue [35S]GTP{gamma}S was followed by measurement of specific binding of [35S]GTP{gamma}S.



View larger version (48K):
[in this window]
[in a new window]
 
Figure 1. Illustration shows amino acid sequence of rat angiotensin II type 1A receptor (from Murphy et al13 ) (amino acid residues 100 through 325). The synthesized peptide sequences are indicated by solid lines and designated as P-1 through P-5.

Effect of Peptides on GTP{gamma}S Binding to G Proteins in Membranes
As shown in Fig 2, peptides P-2, P-3, and P-5 individually activated G proteins for GTP{gamma}S binding in COS-7 cell membranes in a time- and concentration-dependent manner, suggesting that these peptides compete for receptor binding domains of the G proteins. The peptides P-1 and P-4 showed no effect up to 100 µmol/L. Peptides P-2, P-3, and P-5 also activated G proteins in VSMC membranes, and again, P-1 and P-4 showed no effect (data not shown).



View larger version (23K):
[in this window]
[in a new window]
 
Figure 2. Line graphs show effect of synthetic peptides with amino acid sequences of cytosolic loop regions of the rat angiotensin II type 1A (AT1A) receptor on COS-7 membrane G proteins. A, Time course of GTP{gamma}S binding to G proteins in COS-7 cell membranes during treatment with 100 µmol/L of peptides. In the presence of 100 nmol/L [35S]GTP{gamma}S, 5 µg of membranes was incubated for indicated periods with various synthetic peptides corresponding to the cytosolic regions of the AT1A receptor indicated in Fig 1. Values represent the mean of three independent experiments. B, Dose-response relationship for these synthetic peptides on the GTP{gamma}S binding to G protein in COS-7 cell membranes. Membranes (5 µg) were incubated for 10 minutes with each peptide in the same setting as in A. The GTP{gamma}S bound in 10 minutes, when binding was nearly complete as shown in A (100% is control GTP{gamma}S bound in the absence of a peptide), is presented as a function of the concentrations of each peptide examined. Values represent the mean of three independent experiments.

Effect of Peptides on GTP{gamma}S Binding to Purified G Proteins
Several species of G proteins exist in cellular membrane preparations. To determine individual species that interacted with each of the peptides, we examined the effect of all five synthetic peptides on [35S]GTP{gamma}S binding to purified Gi1, Gi2, and Go proteins. As shown in Fig 3, peptides P-3 and P-5 activated purified Gi1, Gi2, and Go. The peptides P-1, P-2, and P-4 showed no effect at 100 µmol/L. P-2 had an effect on [35S]GTP{gamma}S binding to G proteins in the membranes but not on purified Gi1, Gi2, and Go. It is known that AT1A couples with Gq protein,1 2 but we did not examine the effect of the peptides on GTP{gamma}S binding to Gq because we did not have purified Gq. It is possible that P-2 may have an effect on the activation of Gq.



View larger version (12K):
[in this window]
[in a new window]
 
Figure 3. Bar graphs show the effect of synthetic peptides on GTP{gamma}S binding to purified G proteins. Each purified G protein (10 nmol/L) was incubated with 100 nmol/L [35S]GTP{gamma}S at room temperature in the absence (control) or presence of 100 µmol/L synthetic peptide (P-1 to P-5) for 10 minutes. A 50-µL aliquot of reaction mixture was subjected to the analysis of [35S]GTP{gamma}S binding. Total GTP{gamma}S binding to 0.5 pmol G protein was set as 100%. Data represent mean±SD of three independent experiments.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
In this article we describe the use of synthetic peptides derived from the rat AT1A receptor to identify domains of the receptor involved in interactions with G protein. We investigated the several candidate domains of the receptor with two different approaches, one using COS-7 cell membranes and the other using purified G proteins. Peptides P-3 and P-5 produced consistent activation in both assays, strongly indicating a role of the third intracellular loop and C-terminal cytosolic domain in AT1A receptors in G protein coupling. In contrast, none of the other AT1A-derived peptides influenced GTP{gamma}S binding. Our data are consistent with other studies which indicate that the third intracellular loop of a typical seven-transmembrane receptor, such as adrenergic and muscarinic receptors, is important for effective coupling to G protein. The proximal portion of the C-terminal tail of the receptor appears to be another determinant of AT1A association with G protein, as evidenced by the effects produced by P-5 in the assays described. The activity of P-5 in these assays implies that the first one third of the cytoplasmic tail is important for effective AT1A–G protein coupling. Again, it appears that this portion of the AT1A receptor binds G proteins, as indicated by the ability of P-5 to activate GTP{gamma}S binding to Gi1{alpha}, Gi2{alpha}, and Go{alpha}.

The coupling of Go protein with AT1A has not been clarified yet. AT1A receptor and Go protein are expressed abundantly in neuronal cells, and it has been reported that Go inhibits neuronal calcium channels.7 Bacal and Kunze8 reported that Ang II inhibits {omega}-conotoxin GVIA (CTX)–sensitive calcium channels through a pertussis toxin–sensitive G protein coupled to AT1 in rat nodose ganglion cells. This inhibitory effect was abolished by losartan, a specific antagonist, and preincubation with pertussis toxin. These data suggested that Go protein coupled with AT1A in neuronal cells. Mitchell et al3 reported the possibility of direct coupling of AT1A and purified Go protein in a reconstituted system. Our observation provides additional evidence for Go protein coupling with AT1A.

The present results suggest that Gi1, Gi2, and Go proteins were activated by identical domains of AT1A. However, the mechanism of regulation in the activation of each type of G protein is not clear. Ohnishi et al9 reported that Ang II at a low concentration (10-11 mol/L) activated only Gi protein, but at a high concentration (10-8 mol/L) it activated both Gq and Gi proteins. This observation strongly suggested that there are different activation mechanisms for Gq and Gi proteins. In the ß2-adrenergic receptor, the C-terminal one third of the third cytoplasmic loop activates both Gs and Gi, and the activation is also regulated by phosphorylation by cAMP-dependent protein kinase A.21 This domain activates Gs when it is dephosphorylated, whereas when phosphorylated by protein kinase A, this domain activates Gi but not Gs. A similar regulatory mechanism may operate in AT1A receptors.

We were not able to examine the effect of the peptides on GTP{gamma}S binding to Gq protein because we did not have a purified Gq preparation. From our data of GTP{gamma}S binding to G protein in COS-7 membranes, P-2, P-3, and P-5 activated GTP{gamma}S binding, but P-2 did not activate purified Gi1, Gi2, or Go protein. An identical experimental procedure has been used for binding studies with membranes and purified G proteins. Therefore, the positive effect of P-2 to the membrane preparation but not to purified G proteins may be explained by the possible action of P-2 on Gq in the membranes. Indeed, previous data from our laboratory collected with the use of mutated variants of AT1A showed the importance of the second, third, and C-terminal cytosolic regions of AT1A for Gq protein coupling.18 These results suggest a possible interaction of Gq with the second cytosolic domain, presumably P-2, of AT1A.

The present data suggest that the third intracellular loop of AT1A plays a critical role in the interaction of AT1A with G protein in accord with similar observations made with many other G protein–coupled receptors. We also found that the first one third of the C-terminal tail of AT1A is important for the interaction of AT1A and G protein. A report from our laboratory provides an observation indicating that the C-terminal cytosolic tail of AT1A is also a critical region for functional association with G protein.18 The synthetic peptide and mutagenesis studies strongly suggest that the third intracellular loop and C-terminal tail region of AT1A play major roles in the physical and functional coupling of AT1A to G proteins. In contrast, the adrenergic and muscarinic receptors, whose ligands are small nonpeptide molecules, require a part of the third intracellular loop for interaction with G protein.23 24 25 26 27 Cloning of receptors within the G protein–coupled superfamily has revealed that most of the receptors for peptidic ligands possess relatively short third intracellular loops25 compared with the receptors for small ligands. For example, in neutrophil N-formyl peptide receptor, the C-terminal tail region was shown to have an important role for interaction with G protein as well as the second cytosolic loop.28 It seems that many members of this receptor superfamily with short third cytosolic loops require more than one intracellular region for G protein binding. Not a single consensus structure has yet been identified within this receptor superfamily that uniquely defines the G protein binding structure. It may be that individual receptors may use different amino acid sequences in different domains of available intracellular regions. Several reports appeared on possible G protein coupling sites of AT1A in which the site-directed mutagenesis method was used. Bihoreau et al29 and Marie et al30 made mutations in the transmembrane domains II and VII of AT1A, respectively. These mutations resulted in a loss of G protein coupling presumably because of a conformational change that could cause conformational changes in domains other than the mutated amino acid residues. Hunyady et al31 made third cytoplasmic loop deletion mutants of AT1A and reported that the N-terminal half of the third cytoplasmic loop (amino acid residues 215 through 226) was a critical region of Gq protein coupling. A series of mutational studies on basic polar amino acid residues in the second and third cytosolic loops of AT1A by Ohyama et al18 suggested that the N-terminal half of the second cytoplasmic loop and C-terminal half of the third cytosolic loop would be important for Gq protein coupling. These conflicting results could be due to conformational changes that could be introduced by mutational substitutions of amino acid residues. It is interesting that no mutational change has been reported that causes activation of the G protein coupling with the AT1A receptor. Because of the observation of positive activation, the synthetic peptide method for mapping of G protein coupling is useful. For the identification of the domain important for Gq protein coupling with AT1A, purified Gq protein should turn out to be useful in a similar approach using synthetic peptides representing various cytosolic domains.

In summary, the present studies identified that the N-terminal half of the third cytoplasmic loop and C-terminal cytosolic tail of AT1A receptors are important for Gi1, Gi2, and Go protein coupling.


*    Acknowledgments
 
This work was supported in part by research grants HL-14192 from the US Public Health Service and HL-35323 from the National Institutes of Health. We would like to thank Trinita Fitzgerald for her excellent technical assistance.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Inagami T, Iwai N, Sasaki K, Yamano Y, Bardhan S, Chaki S, Guo DF, Furuta H. Cloning, expression and regulation of angiotensin II receptors. J Hypertens. 1992;10:713-716. [Medline] [Order article via Infotrieve]

2. Crawford KW, Frey EA, Cote TE. Angiotensin II receptor recognized by Dup753 regulates two distinct guanine nucleotide-binding protein signaling pathways. Mol Pharmacol. 1992;41:154-162. [Abstract]

3. Mitchell J, Murphy EA, Northup JK. Reconstitution of agonist binding to uncoupled hepatic angiotensin II receptors with Gi and Go. The Endocrine Society Abstract. 1991;199.

4. Smrcka AV, Eerenz CR, Lellaher KL, Kriz RW, Knopf LJ. Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. Science. 1991;251:804-807. [Abstract/Free Full Text]

5. Taylor SJ, Chae CZ, Rhee SG, Exton JH. Activation of the ß1 isozyme of phospholipase C by {alpha} subunits of the Gq class of G proteins. Nature. 1991;350:516-518. [Medline] [Order article via Infotrieve]

6. Gilman AG. G proteins: transducers of receptor-generated signals. Annu Rev Biol. 1987;56:615-649.

7. Hescheler J, Rosenthal W, Trauwein W, Schultz G. The GTP-binding protein Go regulates neuronal calcium channels. Nature. 1987;325:445-447. [Medline] [Order article via Infotrieve]

8. Bacal K, Kunze DL. Dual effects of angiotensin II on calcium currents in neonatal rat nodose neurons. J Neurosci. 1994;14:7159-7167. [Abstract]

9. Ohnishi J, Ishido M, Shibata T, Inagami T, Murakami K, Miyazaki H. The rat angiotensin II AT1a receptor couples with three different signal transduction pathways. Biochem Biophys Res Commun. 1992;186:1094-1101. [Medline] [Order article via Infotrieve]

10. May DC, Ross EM, Gilman AG, Smigel MD. Reconstitution of catecholamine-stimulated adenylate cyclase activity using three purified proteins. J Biol Chem. 1985;260:15829-15833. [Abstract/Free Full Text]

11. Feder D, Im MJ, Klein HW, Hekman M, Holzhofer A, Dees C, Levitzki A, Helmreich EJM, Pfeuffer T. Reconstitution of ß1-adrenoceptor-dependent adenylate cyclase from purified components. EMBO J. 1986;5:1509-1514. [Medline] [Order article via Infotrieve]

12. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature. 1991;351:230-233. [Medline] [Order article via Infotrieve]

13. Murphy TJ, Alexander RW, Griedling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the type-1 angiotensin II receptor. Nature. 1991;351:233-236. [Medline] [Order article via Infotrieve]

14. Takayanagi R, Ohnaka K, Sakai Y, Nakao R, Yanase T, Haji M, Inagami T, Furuta H, Guo DF, Nakamuta M, Nawata H. Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor. Biochem Biophys Res Commun. 1992;183:910-917. [Medline] [Order article via Infotrieve]

15. Furuta H, Guo DF, Inagami T. Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptor. Biochem Biophys Res Commun. 1992;183:8-13. [Medline] [Order article via Infotrieve]

16. Henderson R, Unwin PNT. Three-dimensional model of purple membrane obtained by electron microscopy. Nature. 1975;257:28-32. [Medline] [Order article via Infotrieve]

17. Ovchinnikov YA. Rhodopsin and bacteriorhodopsin: structure-function relationships. FEBS Lett. 1982;148:179-191. [Medline] [Order article via Infotrieve]

18. Ohyama K, Yamano Y, Chaki S, Kondo T, Inagami T. Domains for G-protein coupling in angiotensin II receptor type 1: studies by site-directed mutagenesis. Biochem Biophys Res Commun. 1992;189:1426-1431.

19. Kondo T, Konishi F, Inui H, Inagami T. Differing signal transductions elicited by isoforms of platelet-derived growth factor in vascular smooth muscle cells. J Biol Chem. 1993;268:4458-4464. [Abstract/Free Full Text]

20. Katada T, Oinuma M, Kusakabe K, Ui M. A new GTP-binding protein in brain tissue serving as the specific substrate of islet-activating protein, pertussis toxin. FEBS Lett. 1987;213:353-358. [Medline] [Order article via Infotrieve]

21. Okamoto T, Murayama Y, Hayashi Y, Inagaki M, Ogata E, Nishimoto I. Identification of a Gs activator region of the ß2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell. 1991;67:723-730. [Medline] [Order article via Infotrieve]

22. Northup JK, Smigel MD, Gilman AG. The guanine nucleotide activating site of the regulatory component of adenylate cyclase. J Biol Chem. 1982;257:11416-11423. [Free Full Text]

23. Lefkowitz RJ, Caron MG. Adrenergic receptors, models for the study of receptors coupled to guanine nucleotide regulatory proteins. J Biol Chem. 1988;263:4993-4996. [Free Full Text]

24. Savarese TM, Fraser CM. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem J. 1992;283:1-19.

25. Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol. 1992;2:1-20.

26. Strader CD, Sigal IS, Dixon RA. Structural basis of ß-adrenergic receptor function. FASEB J. 1989;3:1825-1832. [Abstract]

27. Strosberg AD. Structure/function relationship of proteins belonging to the family of receptors coupled to GTP-binding proteins. Eur J Biochem. 1991;196:1-10. [Medline] [Order article via Infotrieve]

28. Schreiber RE, Prossnitz ER, Ye RD, Cochrane CG, Bokoch GM. Domains of the human neutrophil N-formyl peptide receptor involved in G protein coupling. J Biol Chem. 1994;269:326-331. [Abstract/Free Full Text]

29. Bihoureau C, Monnot C, Davies E, Teutsch B, Bernstein KE, Corvol P, Clauser E. Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. Proc Natl Acad Sci U S A. 1993;90:5133-5137. [Abstract/Free Full Text]

30. Marie J, Maigret B, Joseph MP, Larguier R, Nouet S, Lombard C, Bonnafous JC. Tyr292 in the seventh transmembrane domain of the AT1A angiotensin II receptor is essential for its coupling to phospholipase C. J Biol Chem. 1994;269:20815-20818. [Abstract/Free Full Text]

31. Hunyady L, Baukal AJ, Balla T, Catt KJ. Independence of type 1 angiotensin II receptor endocytosis from G protein coupling and signal transduction. J Biol Chem. 1994;269:24798-24804.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
HypertensionHome page
Y.-H. Feng, Y. Ding, S. Ren, L. Zhou, C. Xu, and S. S. Karnik
Unconventional Homologous Internalization of the Angiotensin II Type-1 Receptor Induced by G-Protein-Independent Signals
Hypertension, August 1, 2005; 46(2): 419 - 425.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-Q. Xie and J.-Z. Chen
NMR Structural Comparison of the Cytoplasmic Juxtamembrane Domains of G-protein-coupled CB1 and CB2 Receptors in Membrane Mimetic Dodecylphosphocholine Micelles
J. Biol. Chem., February 4, 2005; 280(5): 3605 - 3612.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Liu, G. Sandford, G. Fei, and J. Nicholas
G{alpha} Protein Selectivity Determinant Specified by a Viral Chemokine Receptor-Conserved Region in the C Tail of the Human Herpesvirus 8 G Protein-Coupled Receptor
J. Virol., March 1, 2004; 78(5): 2460 - 2471.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. B. C. Carvalheira, V. C. Calegari, H. G. Zecchin, W. Nadruz Jr., R. B. Guimaraes, E. B. Ribeiro, K. G. Franchini, L. A. Velloso, and M. J. A. Saad
The Cross-Talk between Angiotensin and Insulin Differentially Affects Phosphatidylinositol 3-Kinase- and Mitogen-Activated Protein Kinase-Mediated Signaling in Rat Heart: Implications for Insulin Resistance
Endocrinology, December 1, 2003; 144(12): 5604 - 5614.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. B. Hansen, H. Castrop, J. Briggs, and J. Schnermann
Adenosine Induces Vasoconstriction through Gi-Dependent Activation of Phospholipase C in Isolated Perfused Afferent Arterioles of Mice
J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2457 - 2465.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. Vazquez, C. Sun, J. Du, L. Fuentes, C. Sumners, and M. K. Raizada
Transduction of a Functional Domain of the AT1 Receptor in Neurons by HIV-Tat PTD
Hypertension, March 1, 2003; 41(3): 751 - 756.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. N. McLaughlin, C. D. Thulin, S. M. Bray, M. M. Martin, T. S. Elton, and B. M. Willardson
Regulation of Angiotensin II-induced G Protein Signaling by Phosducin-like Protein
J. Biol. Chem., September 13, 2002; 277(38): 34885 - 34895.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Thekkumkara and S. L. Linas
Role of internalization in AT1A receptor function in proximal tubule epithelium
Am J Physiol Renal Physiol, April 1, 2002; 282(4): F623 - F629.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Seta, M. Nanamori, J. G. Modrall, R. R. Neubig, and J. Sadoshima
AT1 Receptor Mutant Lacking Heterotrimeric G Protein Coupling Activates the Src-Ras-ERK Pathway without Nuclear Translocation of ERKs
J. Biol. Chem., March 8, 2002; 277(11): 9268 - 9277.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. D Hughes
AT 1-signalling in vascular smooth muscle
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 125 - 130.
[PDF]


Home page
Mol. Pharmacol.Home page
S. Mukhopadhyay, H. H. McIntosh, D. B. Houston, and A. C. Howlett
The CB1 Cannabinoid Receptor Juxtamembrane C-Terminal Peptide Confers Activation to Specific G proteins in Brain
Mol. Pharmacol., January 1, 2000; 57(1): 162 - 170.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. Vezza, A. Habib, and G. A. FitzGerald
Differential Signaling by the Thromboxane Receptor Isoforms via the Novel GTP-binding Protein, Gh
J. Biol. Chem., April 30, 1999; 274(18): 12774 - 12779.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Franzoni, G. Nicastro, T. A. Pertinhez, E. Oliveira, C. R. Nakaie, A. C. M. Paiva, S. Schreier, and A. Spisni
Structure of Two Fragments of the Third Cytoplasmic Loop of the Rat Angiotensin II AT1A Receptor. IMPLICATIONS WITH RESPECT TO RECEPTOR ACTIVATION AND G-PROTEIN SELECTION AND COUPLING
J. Biol. Chem., January 1, 1999; 274(1): 227 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. B. Thompson, S. M. Wade, J. K. Harrison, M. N. Salafranca, and R. R. Neubig
Cotransfection of Second and Third Intracellular Loop Fragments Inhibit Angiotensin AT1a Receptor Activation of Phospholipase C in HEK-293 Cells
J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 216 - 222.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. Sano, K. Ohyama, Y. Yamano, Y. Nakagomi, S. Nakazawa, M. Kikyo, H. Shirai, J. S. Blank, J. H. Exton, and T. Inagami
A Domain for G Protein Coupling in Carboxyl-terminal Tail of Rat Angiotensin II Receptor Type 1A
J. Biol. Chem., September 19, 1997; 272(38): 23631 - 23636.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Saward Peter Zahradka
Angiotensin II Activates Phosphatidylinositol 3-Kinase in Vascular Smooth Muscle Cells
Circ. Res., August 19, 1997; 81(2): 249 - 257.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
B. C. Berk and M. A. Corson
Angiotensin II Signal Transduction in Vascular Smooth Muscle : Role of Tyrosine Kinases
Circ. Res., May 19, 1997; 80(5): 607 - 616.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. Franzoni, G. Nicastro, T. A. Pertinhez, M. Tato, C. R. Nakaie, A. C.M. Paiva, S. Schreier, and A. Spisni
Structure of the C-terminal Fragment 300-320 of the Rat Angiotensin II AT1A Receptor and Its Relevance with Respect to G-Protein Coupling
J. Biol. Chem., April 11, 1997; 272(15): 9734 - 9741.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Macrez-Lepretre, F. Kalkbrenner, J.-L. Morel, G. Schultz, and J. Mironneau
G Protein Heterotrimer Galpha 13beta 1gamma 3 Couples the Angiotensin AT1A Receptor to Increases in Cytoplasmic Ca2+ in Rat Portal Vein Myocytes
J. Biol. Chem., April 11, 1997; 272(15): 10095 - 10102.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. D. D'Angelo, J. J. Eubank, M. G. Davis, and G. W. Dorn II
Mutagenic Analysis of Platelet Thromboxane Receptor Cysteines
J. Biol. Chem., March 15, 1996; 271(11): 6233 - 6240.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shirai, H.
Right arrow Articles by Inagami, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shirai, H.
Right arrow Articles by Inagami, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH